EW Operating Cash Flow Growth
Edwards Lifesciences · Operating Cash Flow Growth
EW Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported116.42%period ending
EW TTM Cash from Operations YoY % (-33.55% → 116.42%)
Year-over-year change
High-resolution chart · PNG
EW operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 116.4172% | |
| 55.0559% | |
| 194.1545% | |
| 26.0913% | |
| -8.2208% | |
| 65.8841% | |
| -39.4619% | |
| -22.6104% | |
| -7.9009% | |
| -57.3688% | |
| -26.4653% | |
| -20.3972% | |
| -38.5761% | |
| -28.1697% | |
| -29.6692% | |
| -25.5616% | |
| 6.1205% | |
| 50.2788% | |
| 64.2891% | |
| 66.8881% | |
| 13.1618% | |
| -17.1204% | |
| -10.6071% | |
| -1.7987% | |
| 30.3579% | |
| 78.2368% | |
| 27.2551% | |
| 7.5474% | |
| 1.2213% | |
| -24.0989% | |
| -7.3848% | |
| 19.0715% | |
| 31.8145% | |
| 41.0832% | |
| 42.0642% | |
| 38.0168% | |
| 21.4179% | |
| 24.353% | |
| 28.1426% | |
| 12.6136% | |
| 73.0791% | |
| -39.0091% | |
| -46.2291% | |
| -48.1834% | |
| -70.3225% | |
| 82.4719% | |
| 116.2682% | |
| 113.2841% | |
| 149.0042% | |
| 6.6084% | |
| 26.458% | |
| 24.9168% | |
| 32.4355% | |
| 82.8933% | |
| 18.8553% | |
| 47.1364% | |
| 34.6939% | |
| 6.1587% | |
| 25.0994% | |
| 18.8536% | |
| 33.3669% | |
| 18.1988% | |
| 52.0871% | |
| 24.1245% | |
| 62.3568% | |
| 145.4754% | |
| 7.8982% | |
| 20.254% | |
| -37.3975% | |
| -57.2059% | |
| -27.117% | |
| -26.4142% | |
| -4.3606% | |
| -0.9228% | |
| -8.9255% | |
| -0.8776% | |
| 10.9842% | |
| 16.3934% | |
| 68.7135% | |
| 43.0265% | |
| 8.6237% | |
| 6.9528% | |
| -24.2525% | |
| -27.6123% | |
| 6.0777% | |
| -0.9581% | |
| 47.6697% | |
| 95.9446% | |
| 51.4231% | |
| 47.9185% | |
| 1.4096% | |
| -15.6797% | |
| -10.4503% | |
| 5.121% | |
| 19.4059% | |
| 15.2885% | |
| -0.2542% | |
| -6.3644% | |
| -26.2774% | |
| -33.5463% |